How much is too much? Folinic acid rescue dose in children with acute lymphoblastic leukaemia (Q67902968)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1832883%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

title

How much is too much? Folinic acid rescue dose in children with acute lymphoblastic leukaemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1832883%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90269-J

5 December 2022

author name string

J. D. Borsi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832883

5 December 2022

F. Wesenberg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832883

5 December 2022

T. Stokland

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832883

5 December 2022

P. J. Moe

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832883

5 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1832883

5 December 2022

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1832883%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 September 2019

https://api.elsevier.com/content/article/PII:027753799190269J?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90269-J

https://api.elsevier.com/content/article/PII:027753799190269J?httpAccept=text/plain

5 December 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90269-J

European Journal of Cancer

5 December 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1832883%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1832883%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1832883%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

1006-1009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1832883%20AND%20SRC:MED&resulttype=core&format=json

Methotrexate systemic clearance influences probability of relapse in children with standard-risk acute lymphocytic leukaemia

19 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90269-J

Systemic clearance of methotrexate in the prognosis of acute lymphoblastic leukemia in children

5 December 2022

2

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90269-J

Modulation of the antitumor effect of methotrexate by low-dose leucovorin in squamous cell head and neck cancer: a randomized placebo-controlled clinical trial

5 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90269-J

Methotrexate infusions in poor prognosis acute lymphoblastic leukemia: II. High-dose methotrexate (HDM) in acute lymphoblastic leukemia in childhood: a pilot study from April 1981

5 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90269-J

Nonparametric Estimation from Incomplete Observations

5 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90269-J

Analysis of Survival Data under the Proportional Hazards Model

5 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90269-J

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

5 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90269-J

A comparative study on the pharmacokinetics of methotrexate in a dose range of 0.5 g to 33.6 g/m2 in children with acute lymphoblastic leukemia.

5 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90269-J

5 December 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1832883%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference